Cargando…
Hyponatremia and extrapontine myelinolysis in a patient with COVID‐19: A case report
Until we have strong evidence to the contrary, symptomatic hyponatremia should be treated with extra caution in COVID‐19 co‐infection patients as the latter could be another risk factor for the development of extrapontine myelinolysis.
Autores principales: | Abd Ur Rehman, Muhammad, Abdulrahman, Abdulrahman Fadhl, Zainab, Aariz, Paksoy, Yahya, Kharma, Nadir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271216/ https://www.ncbi.nlm.nih.gov/pubmed/34267918 http://dx.doi.org/10.1002/ccr3.4463 |
Ejemplares similares
-
Central and Extrapontine Myelinolysis
por: Noukoua, Charlemagne
Publicado: (2016) -
Sequential MRI in pontine and extrapontine myelinolysis following rapid correction of hyponatremia
por: Laureno, Robert, et al.
Publicado: (2018) -
Diagnosis: Osmotic myelinolysis (central pontine myelinolysis and extrapontine myelinolysis)
por: Ahmed, Asrar, et al.
Publicado: (2007) -
Neuropsychological Findings of Extrapontine Myelinolysis without Central Pontine Myelinolysis
por: Seok, Jung Im, et al.
Publicado: (2007) -
Extrapontine myelinolysis presenting as acute parkinsonism
por: Sajith, J, et al.
Publicado: (2006)